Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
MediWound
MDWD
$174M
| $569K | ﹤0.01% |
55,944
+1,000
| +2% | +$8.98K |
|
2727
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.6B
| $566K | ﹤0.01% |
+29,100
| New | +$552K |
|
2728
ProShares Short Russell2000
RWM
$98.9M
| $565K | ﹤0.01% |
+26,800
| New | +$644K |
|
2729
MeiraGTx Holdings
MGTX
$1.25B
| $564K | ﹤0.01% |
+80,400
| New | +$397K |
|
2730
PLAYSTUDIOS Inc
MYPS
$63.1M
| $564K | ﹤0.01% |
208,300
+68,300
| +49% | +$186K |
|
|
ESGR
2731
DELISTED
Enstar Group
ESGR
| $559K | ﹤0.01% |
1,900
-9,900
| -84% | -$2.59M |
|
2732
Telecom Argentina
TEO
$5.75B
| $557K | ﹤0.01% |
77,887
+56,766
| +269% | +$364K |
|
2733
ESS Tech
GWH
$20.4M
| $552K | ﹤0.01% |
+32,280
| New | +$655K |
|
2734
Absci
ABSI
$1.58B
| $549K | ﹤0.01% |
130,600
-170,200
| -57% | -$316K |
|
2735
Consensus Cloud Solutions
CCSI
$716M
| $548K | ﹤0.01% |
20,900
+1,705
| +9% | +$40K |
|
|
TSRI
2736
DELISTED
TSR Inc. New
TSRI
| $547K | ﹤0.01% |
60,376
-1,974
| -3% | -$17K |
|
2737
Futu Holdings
FUTU
$14.8B
| $546K | ﹤0.01% |
10,000
-8,500
| -46% | -$483K |
|
2738
Stereotaxis
STXS
$137M
| $545K | ﹤0.01% |
311,600
+21,900
| +8% | +$35.4K |
|
|
SPRB
2739
Spruce Biosciences
SPRB
$151M
| $542K | ﹤0.01% |
2,468
-302
| -11% | -$34.9K |
|
2740
Healthcare Services Group
HCSG
$1.48B
| $541K | ﹤0.01% |
52,164
-8,659
| -14% | -$86.4K |
|
2741
Tandem Diabetes Care
TNDM
$1.58B
| $539K | ﹤0.01% |
+18,227
| New | +$378K |
|
2742
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $537K | ﹤0.01% |
+4,400
| New | +$337K |
|
2743
Patria Investments
PAX
$1.86B
| $532K | ﹤0.01% |
34,300
+15,100
| +79% | +$214K |
|
|
SRG
2744
Seritage Growth Properties
SRG
$128M
| $531K | ﹤0.01% |
+56,800
| New | +$477K |
|
2745
UTStarcom
UTSI
$23.5M
| $528K | ﹤0.01% |
153,526
-18,700
| -11% | -$65.3K |
|
2746
Kelly Services Class A
KELYA
$558M
| $526K | ﹤0.01% |
+24,308
| New | +$482K |
|
2747
iShares Core US REIT ETF
USRT
$4.64B
| $521K | ﹤0.01% |
+9,600
| New | +$470K |
|
2748
Dimensional Core Fixed Income ETF
DFCF
$10.9B
| $520K | ﹤0.01% |
+12,271
| New | +$502K |
|
2749
Senseonics Holdings Inc
SENS
$413M
| $520K | ﹤0.01% |
+45,605
| New | +$521K |
|
|
KALV
2750
DELISTED
KalVista Pharmaceuticals
KALV
| $518K | ﹤0.01% |
42,300
-26,800
| -39% | -$244K |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.